Post-approval studies (Phase 4)Study completedNCT00970528What this trial is testingGlucose Reduction by Early Acarbose Treatment in Basal InsulinWho this might be right forDiabetes Mellitus, Type 2 Bayer 124
Large-scale testing (Phase 3)Study completedNCT01456195What this trial is testingComparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2 Takeda 421
Post-approval studies (Phase 4)Study completedNCT00941369What this trial is testingHealth Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes PatientsWho this might be right forDiabetes Mellitus, Type 2 Sanofi 345
Large-scale testing (Phase 3)Study completedNCT01257451What this trial is testingSafety and Efficacy of Galvus in Elderly Type 2 Diabetes PatientsWho this might be right forType 2 Diabetes Mellitus Novartis Pharmaceuticals 431
Large-scale testing (Phase 3)Study completedNCT01204294What this trial is testingComprehensive Add on Study in JapanWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 574
Post-approval studies (Phase 4)Study completedNCT00184561What this trial is testingEffectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 321
Early research (Phase 1)Study completedNCT02940379What this trial is testingA Drug to Drug Interaction Study of Sotagliflozin With Midazolam and MetoprololWho this might be right forType 2 Diabetes Mellitus Sanofi 24
Early research (Phase 1)Study completedNCT00115973What this trial is testingThe Treatment of Type 2 Diabetes With an Insulin Infusion PumpWho this might be right forDiabetesDiabetes Mellitus, Type 2Delivery Systems Novo Nordisk A/S 71
Testing effectiveness (Phase 2)Study completedNCT00328172What this trial is testingEfficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 302
Large-scale testing (Phase 3)Study completedNCT01001611What this trial is testingAn Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 Chong Kun Dang Pharmaceutical 173
Large-scale testing (Phase 3)Study completedNCT01697592What this trial is testingOmarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 585
Early research (Phase 1)Study completedNCT07266779What this trial is testingBioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.Who this might be right forType 2 Diabetes Humanis Saglık Anonim Sirketi 36
Early research (Phase 1)Study completedNCT07372118What this trial is testingBioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast ConditionWho this might be right forType 2 Diabetes Mellitus (T2DM) Humanis Saglık Anonim Sirketi 32
Large-scale testing (Phase 3)Study completedNCT00641043What this trial is testingEfficacy vs Placebo as Initial Combination Therapy With PioglitazoneWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 389
Early research (Phase 1)Study completedNCT06124573What this trial is testingBioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.Who this might be right forBioequivalenceDiabetes Mellitus, Type 2 Galenicum Health 48
Early research (Phase 1)Study completedNCT06124547What this trial is testingBioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.Who this might be right forBioequivalenceDiabetes Mellitus, Type 2 Galenicum Health 48
Post-approval studies (Phase 4)Study completedNCT02606357What this trial is testingTreatment of Type 2 Diabetes With Long Acting Basal Insulin in JordanWho this might be right forDiabetes Mellitus, Type 2 Sanofi 242
Testing effectiveness (Phase 2)Study completedNCT00065312What this trial is testingAn Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 DiabetesWho this might be right forDiabetes Mellitus, Non-Insulin-Dependent Eli Lilly and Company
Post-approval studies (Phase 4)Study completedNCT00311818What this trial is testingInsulin Glargine in Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Sanofi
Post-approval studies (Phase 4)Study completedNCT01972724What this trial is testingEfficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyWho this might be right forType II Diabetes Mellitus Takeda 114